Concord Wealth Partners

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1814214 ABINGDON, VA

Position in ALNY

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$60,206

-$19,324 QoQ

Shares Held

200

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#621

of 784 holders

Holding Since

Mar 2021

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Concord Wealth Partners holds $158,287 across 14 Biotechnology names. ALNY ranks #2 (38.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	213	$79,165
2	ALNY	Alnylam Pharmaceuticals, Inc. This page	200	$60,206
3	AGIO	Agios Pharmaceuticals, Inc.	200	$7,422
4	HALO	Halozyme Therapeutics, Inc.	66	$5,165
5	TECH	BIO-TECHNE Corp	44	$3,108
6	FTRE	Fortrea Holdings Inc.	60	$1,044
7	CRSP	CRISPR Therapeutics AG	11	$599
8	MIRM	Mirum Pharmaceuticals, Inc.	5	$585

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$60,206	200	0.0%	Shares	Sole	2026-07-27
2025-12-31	$79,530	200	0.0%	Shares	Sole	2026-01-29
2025-09-30	$91,200	200	0.0%	Shares	Sole	2025-11-05
2025-06-30	$65,218	200	0.0%	Shares	Sole	2025-07-25
2025-03-31	$54,004	200	0.0%	Shares	Sole	2025-05-02
2024-12-31	$47,062	200	0.0%	Shares	Sole	2025-01-24
2024-09-30	$55,006	200	0.0%	Shares	Sole	2024-10-24
2024-06-30	$48,600	200	+1076.5%	Shares	Sole	2024-07-31
2022-06-30	$2,479	17	-86.7%	Shares	Sole	2022-08-04
2022-03-31	$20,901	128	+7.6%	Shares	Sole	2022-04-20
2021-12-31	$20,180	119	+46.9%	Shares	Sole	2022-01-21
2021-09-30	$15,293	81	+62.0%	Shares	Sole	2021-11-09
2021-06-30	$8,476	50	+13.6%	Shares	Sole	2021-07-29
2021-03-31	$6,212	44	—	Shares	Sole	2021-05-13
No filing history on record for this holder in this stock.